Myopia Progression Clinical Trials

12 recruitingLast updated: May 21, 2026

There are 12 actively recruiting myopia progression clinical trials across 8 countries. Studies span Not Applicable, Phase 3. Top locations include Auckland, New Zealand, Beaumont, Texas, United States, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Myopia Progression Trials at a Glance

12 actively recruiting trials for myopia progression are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Auckland, Beaumont, and Beijing. Lead sponsors running myopia progression studies include SightGlass Vision, Inc., nthalmic Pty Ltd, and Essilor International.

Browse myopia progression trials by phase

About Myopia Progression Clinical Trials

Looking for clinical trials for Myopia Progression? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Myopia Progression trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Myopia Progression clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Children's Viewing Behavior

MyopiaMyopia ProgressionJuvenile Myopia
SightGlass Vision, Inc.20 enrolled1 locationNCT07229365
Recruiting
Not Applicable

Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses

MyopiaMyopia ProgressionJuvenile Myopia
SightGlass Vision, Inc.20 enrolled1 locationNCT07229352
Recruiting
Not Applicable

Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years

Myopia Progression
Essilor International76 enrolled1 locationNCT07462897
Recruiting
Phase 3

The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children

Myopia Progression
Aston University66 enrolled1 locationNCT07535749
Recruiting
Not Applicable

Effect of MiYOSMART iQ Spectacle Lenses on Myopia Progression in Children

Myopia, Child Myopia Progression
Hoya Lens Rus LLC70 enrolled1 locationNCT07387159
Recruiting
Phase 3

Atropine in the Treatment of Myopia Study in Malaysia

Myopia Progression
IDB VisionCare SDN BHD144 enrolled2 locationsNCT07329777
Recruiting
Not Applicable

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens

MyopiaMyopia ProgressionJuvenile Myopia
SightGlass Vision, Inc.150 enrolled14 locationsNCT06034327
Recruiting
Not Applicable

The A.R.R.E.S.T.® Contact Lens Study

MyopiaMyopia Progression
nthalmic Pty Ltd80 enrolled2 locationsNCT06878118
Recruiting
Not Applicable

Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)

MyopiaMyopia; Refractive ErrorMyopia Progression+2 more
National University of Singapore396 enrolled5 locationsNCT06631339
Recruiting
Not Applicable

The A.R.R.E.S.T.® Spectacle Film Study

MyopiaMyopia Progression
nthalmic Pty Ltd160 enrolled1 locationNCT06692699
Recruiting
Phase 3

The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression

MyopiaMyopia Progression
Oupushifang Pharmaceutical Technology Co., Ltd.606 enrolled25 locationsNCT06708156
Recruiting

Factors Influencing Physiological Hyperopia in Children

Myopia Progression
Beijing Tongren Hospital1,006 enrolled1 locationNCT06498947